Loading clinical trials...
Loading clinical trials...
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Conditions
Interventions
BAY94-9027
Locations
59
United States
Tucson, Arizona, United States
Sacramento, California, United States
San Diego, California, United States
Jacksonville, Florida, United States
Miami, Florida, United States
Chicago, Illinois, United States
Start Date
April 23, 2012
Primary Completion Date
June 13, 2014
Completion Date
November 21, 2019
Last Updated
November 7, 2023
NCT06820515
NCT07226206
NCT05987449
NCT04563520
NCT04645199
NCT06833983
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions